Rocket Companies shares rise 1.02% premarket after Rocket Doctor's patient volume grew 112% in Alberta.

Rocket Companies, Inc. rose 1.02% in premarket trading, with the company's Rocket Doctor division experiencing significant growth in patient volume and physician adoption. The division also launched new partnerships in California and Canada, and its Medical Education Suite was deployed at the University of Minnesota, delivering scalable AI-driven clinical training and potential cost savings. Additionally, Rocket Doctor was named a Top Clinical Innovator by the American Telemedicine Association.